Skip to main content

Table 2 List of 23 lipid candidate biomarkers with significant fold-change > 1.5 following the 12-week MRP

From: Circulating sphingolipids and relationship to cardiac remodelling before and following a low-energy diet in asymptomatic Type 2 Diabetes

No

BIOCHEMICAL

COMP ID

Sub-family

Fold Change

Direction Δ from BL

Adjusted P value (FDR = 0.05)

1

nisinate (24:6n3)

57810

Long Chain Polyunsaturated Fatty Acid (n3 and n6)

-2.08

↓

0.005

2

1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)

52682

Plasmalogen

0.81

↑

0.002

3

1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1)

52478

Plasmalogen

0.71

↑

< 0.001

4

1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)

52713

Plasmalogen

0.77

↑

< 0.001

5

1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)

52716

Plasmalogen

0.80

↑

0.003

6

1-(1-enyl-palmitoyl)-GPC (P-16:0)

52474

Lysoplasmalogen

0.64

↑

0.004

7

1-palmitoyl-2-oleoyl-GPE (16:0/18:1)

19263

Phosphatidylethanolamine (PE)

-1.55

↓

0.003

8

1-stearoyl-2-oleoyl-GPE (18:0/18:1)

42448

Phosphatidylethanolamine (PE)

-1.88

↓

0.001

9

butyrylcarnitine (C4)

32412

Fatty Acid Metabolism

-1.39

↓

0.005

10

dihomo-linoleoylcarnitine (C20:2)

57520

Fatty Acid Metabolism (Acyl Carnitine, Polyunsaturated)

0.72

↑

0.003

11

eicosenoylcarnitine (C20:1)

57519

Fatty Acid Metabolism (Acyl Carnitine, Monounsaturated)

0.69

↑

0.002

12

hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH))

62851

Sphingomyelins

0.85

↑

0.004

13

sphingomyelin (d18:1/20:2, d18:2/20:1, d16:1/22:2)

57481

Sphingomyelins

0.70

↑

0.001

14

sphingomyelin (d18:1/22:2, d18:2/22:1, d16:1/24:2)

57477

Sphingomyelins

0.80

↑

0.002

15

sphingomyelin (d18:2/16:0, d18:1/16:1)

42459

Sphingomyelins

0.89

↑

0.004

16

sphingomyelin (d18:2/18:1)

57474

Sphingomyelins

0.83

↑

0.004

17

sphingomyelin (d18:2/23:1)

57482

Sphingomyelins

0.85

↑

0.007

18

sphingomyelin (d18:2/24:1, d18:1/24:2)

52437

Sphingomyelins

0.80

↑

< 0.001

19

sphingomyelin (d18:2/24:2)

57479

Sphingomyelins

0.73

↑

< 0.001

20

glycosyl ceramide (d18:2/24:1, d18:1/24:2)

57453

Hexosylceramides (HCER)

0.71

↑

0.001

21

glycosyl-N-nervonoyl-sphingosine (d18:1/24:1)

57369

Hexosylceramides (HCER)

0.72

↑

< 0.001

22

lactosyl-N-nervonoyl-sphingosine (d18:1/24:1)

57370

Lactosylceramides (LCER)

0.76

↑

0.001

23

lactosyl-N-palmitoyl-sphingosine (d18:1/16:0)

53010

Lactosylceramides (LCER)

0.76

↑

< 0.001

  1. Lipids with statistically significant fold-change pre- to post-MRP (calculated as baseline/week 12)